日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Oncogenic GPRIN1 sustains proliferation and mitochondrial homeostasis via dual‑layer CDK1-PI3K/Akt signalling in gallbladder cancer.

致癌基因 GPRIN1 通过双层 CDK1-PI3K/Akt 信号通路维持胆囊癌的增殖和线粒体稳态。

期刊:Cell Death & Disease
影响因子:9.6
doi:10.1038/s41419-026-08550-2
Xu Chang, Gong Zijun, Ni Xiaojian, Nan Lingxi, Sun Wentao, Liu Houbao, Luo Xuanming, Li Min
胆囊癌
信号转导
AKT
CDK1
PI3K/Akt
线粒体
发表日期：2026
文献求助 收藏

Retraction: Loss of FOXN3 in colon cancer activates beta-catenin/TCF signaling and promotes the growth and migration of cancer cells

撤稿声明：结肠癌中FOXN3的缺失激活β-catenin/TCF信号通路，促进癌细胞的生长和迁移

期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.28832
Dai, Yuedi; Wang, Meixing; Wu, Haixia; Xiao, Mi; Liu, Houbao; Zhang, Dexiang
肿瘤
肠癌
肿瘤免疫
信号转导
细胞生物学
发表日期：2026
文献求助 收藏

Targeting E2F8 sensitizes gemcitabine-resistant gallbladder cancer to PARP inhibitors by disrupting RRM2-driven DNA repair.

靶向 E2F8 可破坏 RRM2 驱动的 DNA 修复，从而使吉西他滨耐药的胆囊癌对 PARP 抑制剂敏感。

期刊:Journal of Experimental & Clinical Cancer Research
影响因子:12.8
doi:10.1186/s13046-025-03586-2
Ni Xiaojian, Li Min, Qiu Wenqing, Han Jichang, Yu Meng, Zhang Shulong, Zheng Bohao, He Jiaqi, Liu Houbao
胆囊癌
肿瘤
E2F8
PARP
发表日期：2025
文献求助 收藏

The DCDC2/ENO1 axis promotes tumor progression and immune evasion in intrahepatic cholangiocarcinoma via activating FGL1-LAG3 checkpoint.

DCDC2/ENO1 轴通过激活 FGL1-LAG3 检查点促进肝内胆管癌的肿瘤进展和免疫逃逸

期刊:Journal of Experimental & Clinical Cancer Research
影响因子:12.8
doi:10.1186/s13046-025-03436-1
Wan Wenze, Li Yuan, Sun Wentao, Cheng Zewei, Ma Fen, Shen Sheng, Liu Houbao, Zhang Jiwei
肿瘤
Checkpoint
肿瘤免疫
发表日期：2025
文献求助 收藏

Fasting inhibits glycolysis and migration/invasion in gallbladder cancer via PCBP2/ANGPTL4 signaling.

禁食通过 PCBP2/ANGPTL4 信号通路抑制胆囊癌的糖酵解和迁移/侵袭。

期刊:Cell Cycle
影响因子:3.4
doi:10.1080/15384101.2025.2540137
Tao Ying, Shen Sheng, Gong Zijun, Zan Rui, Zheng Bohao, Ma Chaolin, Wang Jin'e, Liu Han, Ni Xiaoling, Liu Houbao, Suo Tao
胆囊癌
信号转导
CBP
发表日期：2025
文献求助 收藏

CircRNome-wide characterisation reveals the promoting role of circAATF in anti-PD-L1 immunotherapy of gallbladder carcinoma

环状RNA全基因组特征分析揭示了circAATF在胆囊癌抗PD-L1免疫治疗中的促进作用

期刊:Clinical and Translational Medicine
影响因子:6.8
doi:10.1002/ctm2.70060
Wang, Yueqi; Li, Shengli; Bo, Xiaobo; Li, Yuan; Wang, Changcheng; Nan, Lingxi; Zhang, Dexiang; Liu, Houbao; Zhang, Jiwei
肿瘤
肿瘤免疫
PD-L1
AATF
胆囊癌
免疫/内分泌
发表日期：2024
文献求助 收藏

3D-Networks Based Polymer Composites for Multifunctional Thermal Management and Electromagnetic Protection: A Mini Review

基于三维网络的聚合物复合材料在多功能热管理和电磁防护中的应用：简述

期刊:Materials
影响因子:3.2
doi:10.3390/ma17102400
Liu, Houbao; Ji, Xiaohu; Wang, Wei; Zhou, Lihua
发表日期：2024
文献求助 收藏

ASAP1 promotes extrahepatic cholangiocarcinoma progression by regulating the Wnt/β-catenin pathway in vitro and in vivo

ASAP1通过在体外和体内调控Wnt/β-catenin通路促进肝外胆管癌的进展。

期刊:American Journal of Cancer Research
影响因子:2.9
doi:10.62347/RKQX3504
He, Jiaqi; Liu, Han; Cai, Jianhua; Shen, Sheng; Wang, Jiwen; Liu, Houbao
肿瘤
肿瘤免疫
信号转导
Wnt/β-Catenin
胆管癌
发表日期：2024
文献求助 收藏

Insight of novel biomarkers for papillary thyroid carcinoma through multiomics

通过多组学方法深入了解乳头状甲状腺癌的新型生物标志物

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2023.1269751
Liu, Wei; Zhu, Junkan; Wu, Zhen; Yin, Yongxiang; Wu, Qiao; Wu, Yiming; Zheng, Jiaojiao; Wang, Cong; Chen, Hongyan; Qazi, Talal Jamil; Wu, Jun; Zhang, Yuqing; Liu, Houbao; Yang, Jingmin; Lu, Daru; Zhang, Xumin; Ai, Zhilong
甲状腺癌
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2023
文献求助 收藏

Publication Trends of Research on Gallbladder Cancer During 2001-2021: A 20-Year Bibliometric Analysis

2001-2021年胆囊癌研究论文发表趋势：一项为期20年的文献计量分析

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2022.932797
Sun, Wentao; Wan, Wenze; Gao, Zhihui; Suo, Tao; Shen, Sheng; Liu, Houbao
肿瘤
肿瘤免疫
胆囊癌
发表日期：2022
文献求助 收藏